Bone Density Conservation Agents Concept

subject area of

• 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary  Academic Article
• 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis  Academic Article
• 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis  Academic Article
• In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada  Academic Article
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate on Bone Mineral Density and Bone Remodelling in Perimenopausal Women With Low Bone Mineral Density  Conference Paper
• A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures  Academic Article
• A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab  Academic Article
• A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial  Academic Article
• A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis  Academic Article
• A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events  Academic Article
• A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer  Academic Article
• A reappraisal of generic bisphosphonates in osteoporosis  Academic Article
• A retrospective observational study of osteoporosis management after a fragility fracture in primary care  Academic Article
• Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data  Academic Article
• Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials  Academic Article
• Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey  Academic Article
• Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study  Academic Article
• Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis  Academic Article
• Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial)  Academic Article
• Alendronate Therapy in Men With Primary Hyperparathyroidism  Academic Article
• Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study  Academic Article
• An interdisciplinary knowledge translation intervention in long-term care: Study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial  Academic Article
• Anabolic Agents: A New Chapter in the Management of Osteoporosis  Academic Article
• Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture  Academic Article
• Are Oral Bisphosphonates Effective in Improving Lumbar Bone Mineral Density in Breast Cancer Survivors With Osteopenia or Osteoporosis?  Academic Article
• Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study  Academic Article
• Association Between Change in BMD and Fragility Fracture in Women and Men*  Academic Article
• Association between timing of zoledronic acid infusion and hip fracture healing  Academic Article
• Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS)  Academic Article
• Asymptomatic Primary Hyperparathyroidism—Commentary on Current Management  Academic Article
• Atypical Femoral Fractures in Patients Taking Longterm Alendronate  Academic Article
• Atypical Femoral Fractures: A Teaching Perspective  Academic Article
• Atypical femoral fracture  Academic Article
• Bisphosphonate Associated Osteonecrosis of the Jaw  Academic Article
• Bisphosphonate Therapy for Reduced Bone Mineral Density During Treatment of Acute Lymphoblastic Leukemia in Childhood and Adolescence  Academic Article
• Bisphosphonate drug holidays: we reap what we sow  Academic Article
• Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada  Academic Article
• Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review  Academic Article
• Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.  Academic Article
• Bisphosphonates: are they standard of care for the treatment of breast cancer?  Academic Article
• Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer  Academic Article
• Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline  Academic Article
• Calcium and vitamin D for osteoporotic fracture prevention  Academic Article
• Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.  Academic Article
• Cancer-associated bone disease  Academic Article
• Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ  Academic Article
• Change in Quantitative Ultrasound-assessed Speed of Sound as a Function of Age in Women and Men and Association With the Use of Antiresorptive Agents: The Canadian Multicentre Osteoporosis Study  Academic Article
• Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents  Academic Article
• Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis  Academic Article
• Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study  Academic Article
• Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis  Academic Article
• Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis  Academic Article
• Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients  Academic Article
• Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis  Academic Article
• Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis  Academic Article
• Cost-effectiveness of alternative treatments for women with osteoporosis in Canada  Academic Article
• Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada  Academic Article
• Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada  Academic Article
• Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing  Academic Article
• Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial  Academic Article
• Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis  Academic Article
• Denosumab: mechanism of action and clinical outcomes  Academic Article
• Determinants of Vitamin D Status in Early Infancy  Academic Article
• Diagnosis and treatment of Paget’s disease of bone  Academic Article
• Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women  Academic Article
• Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial  Academic Article
• Drug Insight: choosing a drug treatment strategy for women with osteoporosis—an evidence-based clinical perspective  Academic Article
• Drug-Related Adverse Events of Osteoporosis Therapy  Academic Article
• Drugs for pre-osteoporosis: prevention or disease mongering?  Academic Article
• Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate  Academic Article
• Effect of Bisphosphonates on Periprosthetic Bone Mineral Density After Total Joint Arthroplasty  Academic Article
• Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2  Academic Article
• Effect of bisphosphonates on pain and quality of life in patients with bone metastases  Academic Article
• Effectiveness and safety of vitamin D in relation to bone health.  Academic Article
• Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study  Academic Article
• Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial  Academic Article
• Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease  Conference Paper
• Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study  Academic Article
• Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review  Academic Article
• Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis  Academic Article
• Fracture risk and treatment in chronic kidney disease  Academic Article
• Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study  Academic Article
• Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada  Academic Article
• Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study  Academic Article
• Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years  Academic Article
• Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study  Academic Article
• Glucocorticoid induced osteoporosis  Academic Article
• Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis  Academic Article
• Heterotopic Ossification  Academic Article
• Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data  Academic Article
• Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial  Academic Article
• Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis  Academic Article
• Improvement in health-related quality of life in osteoporosis patients treated with teriparatide  Academic Article
• Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) program  Academic Article
• In whom and how to prevent glucocorticoid-induced osteoporosis  Academic Article
• Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: A national observational study  Academic Article
• Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study  Academic Article
• Insufficient evidence to support the use of locally delivered bisphosphonates to improve dental implant outcomes  Academic Article
• Interventions for the treatment of decreased bone mineral density associated with HIV infection  Academic Article
• Legacy Drug-Prescribing Patterns in Primary Care  Academic Article
• Management of Glucocorticoid-Induced Osteoporosis  Academic Article
• Medical Management of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop  Conference Paper
• Micrometer-Sized Magnesium Whitlockite Crystals in Micropetrosis of Bisphosphonate-Exposed Human Alveolar Bone  Academic Article
• Middle East and North Africa consensus on osteoporosis.  Academic Article
• Monitoring strontium ranelate therapy in patients with osteoporosis  Academic Article
• Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study  Academic Article
• Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity  Academic Article
• Non-compliance: the Achilles' heel of anti-fracture efficacy  Academic Article
• Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid  Academic Article
• Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss  Academic Article
• OSTEONECROSIS OF THE JAW: AN UPDATE FOR DENTISTS.  Academic Article
• Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW  Academic Article
• Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting  Conference Paper
• Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture  Academic Article
• Optimal management of metastatic bone disease  Academic Article
• Oral bisphosphonate use in the elderly is not associated with acute kidney injury  Academic Article
• Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS  Academic Article
• Osteonecrosis of the jaw: new developments in an old disease.  Academic Article
• Osteoporosis Knowledge and Information Needs in Healthcare Professionals Caring for Patients With Fragility Fractures  Academic Article
• Osteoporosis Prescribing in Long-Term Care: Impact of a Provincial Knowledge Translation Strategy  Academic Article
• Osteoporosis in Pediatric Patients Suffering From Chronic Inflammatory Bowel Disease With and Without Steroid Treatment  Academic Article
• Osteoporosis management among residents living in long-term care  Academic Article
• Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage  Academic Article
• Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study  Academic Article
• Osteoporosis quality indicators using healthcare utilization data  Academic Article
• Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27  Academic Article
• Osteoporosis treatment rate following hip fracture in a community hospital  Academic Article
• Ostéoporose pendant la ménopause  Academic Article
• Outside the Bone: What Is Happening Systemically to Influence Fracture Healing?  Academic Article
• Patient Adherence to Osteoporosis Medications  Academic Article
• Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study  Academic Article
• Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women.  Academic Article
• Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey  Academic Article
• Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study  Academic Article
• Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study  Academic Article
• Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program  Academic Article
• Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians  Academic Article
• Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy  Academic Article
• Postmenopausal Osteoporosis  Academic Article
• Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer  Academic Article
• Prescription of Vitamin D to Fracture Patients  Academic Article
• Prevention, Diagnosis, and Treatment of Glucocorticoid Induced Osteoporosis by Rheumatologists in a Latin-American City  Academic Article
• Randomized Active and Placebo-Controlled Endoscopy Study of a Novel Protected Formulation of Oral Alendronate  Academic Article
• Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy  Academic Article
• Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.  Academic Article
• Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy  Academic Article
• Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”  Academic Article
• Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.  Academic Article
• Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA  Academic Article
• Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update  Academic Article
• Romosozumab Treatment in Postmenopausal Women with Osteoporosis  Academic Article
• Romosozumab in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture  Academic Article
• Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis  Academic Article
• Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?  Academic Article
• Screening to prevent fragility fractures among adults 40 years and older in primary care: protocol for a systematic review  Academic Article
• Self-perception of fracture risk: what can it tell us?  Academic Article
• Similar Proportions of Women Lose Bone Mineral Density With Raloxifene or Alendronate Treatment  Academic Article
• Strategies to overcome barriers to implementing osteoporosis and fracture prevention guidelines in long-term care: a qualitative analysis of action plans suggested by front line staff in Ontario, Canada  Academic Article
• Strontium ranelate for preventing and treating postmenopausal osteoporosis  Academic Article
• Strontium ranelate for preventing and treating postmenopausal osteoporosis  Academic Article
• Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture  Academic Article
• Subtrochanteric Fractures in Bisphosphonate-Naive Patients: Results from the HORIZON-Recurrent Fracture Trial  Academic Article
• Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial  Academic Article
• Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study  Academic Article
• Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings  Academic Article
• The Effects of Antifracture Therapies on the Components of Bone Strength: Assessment of Fracture Risk Today and in the Future  Academic Article
• The Efficacy and Safety of Abaloparatide‐SC in Men With Osteoporosis: A Randomized Clinical Trial  Academic Article
• The IOC consensus statement: beyond the Female Athlete Triad—Relative Energy Deficiency in Sport (RED-S)  Academic Article
• The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review  Academic Article
• The burden of illness of osteoporosis in Canada  Academic Article
• The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study  Academic Article
• The management of osteoporosis in children  Academic Article
• The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study  Academic Article
• The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women  Academic Article
• The role of Denosumab in joint preservation for patients with giant cell tumour of bone  Academic Article
• The role of bisphosphonates in early- and advanced-stage breast cancer: have we finally optimized care?  Academic Article
• The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC)  Academic Article
• Therapies for Preventing Bone Loss with Glucocorticoid Treatment  Academic Article
• Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial  Academic Article
• Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study  Academic Article
• Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease  Academic Article
• Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?  Academic Article
• Treatment failure in osteoporosis  Academic Article
• Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline  Academic Article
• Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis  Academic Article
• Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study  Academic Article
• Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline  Academic Article
• Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update  Academic Article
• Use of Osteobiologics in the Management of Osteoporotic Fractures  Academic Article
• Vitamin D Monitoring with Antiepileptic Drug Use in Psychiatry  Academic Article
• What Is the Role of Vitamin D Supplementation in Acute Fracture Patients? A Systematic Review and Meta-Analysis of the Prevalence of Hypovitaminosis D and Supplementation Efficacy  Academic Article
• What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention?  Academic Article
• Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis  Academic Article
• Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity  Academic Article
• Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity.  Academic Article
• Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial  Academic Article
• Zoledronic acid use in cancer patients  Academic Article